|
HRP20130810T1
(en)
|
2004-03-11 |
2013-09-30 |
4Sc Ag |
Sulphonylpyrroles as hdac inhibitors
|
|
MY149038A
(en)
*
|
2004-05-26 |
2013-07-15 |
Eisai R&D Man Co Ltd |
Cinnamide compound
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
CA2580119A1
(en)
|
2004-10-26 |
2006-05-04 |
Eisai R & D Management Co., Ltd. |
Amorphous object of cinnamide compound
|
|
AU2006204724A1
(en)
|
2005-01-14 |
2006-07-20 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
|
|
PT1861365E
(pt)
|
2005-03-15 |
2009-09-22 |
4Sc Ag |
N-sulfonilpirroles e a sua utilização como inibidores de histona-desacetilase
|
|
CR9465A
(es)
*
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
FR2886844B1
(fr)
*
|
2005-06-09 |
2007-09-14 |
Oreal |
Utilisation de composes 2-oxy-acetamide pour favoriser et/ou induire et/ou stimuler la pigmentation des matieres keratiniques et/ou limiter leur depigmentation et/ou leur blanchiment
|
|
WO2007008926A1
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
BRPI0617167B8
(pt)
|
2005-09-21 |
2021-05-25 |
Nycomed Gmbh |
sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação
|
|
CN101287706A
(zh)
|
2005-09-21 |
2008-10-15 |
尼科梅德有限责任公司 |
作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐
|
|
EP1953151A4
(en)
*
|
2005-11-18 |
2010-06-02 |
Eisai R&D Man Co Ltd |
SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF
|
|
AU2006316005A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Eisai R & D Management Co., Ltd. |
Process for production of cinnamamide derivative
|
|
RU2381225C1
(ru)
|
2005-11-24 |
2010-02-10 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Производное циннамида типа морфолина
|
|
TWI370130B
(en)
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
|
EP2455382B1
(en)
|
2005-12-13 |
2016-10-26 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
JP5583346B2
(ja)
*
|
2006-01-18 |
2014-09-03 |
エルジー ハウスホールド アンド ヘルスケア リミテッド |
ｃ−Ｋｉｔ活性阻害剤、及び、肌美白剤
|
|
TWI378091B
(en)
*
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
WO2007125321A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Purine and deazapurine derivatives as pharmaceutical compounds
|
|
CA2652484A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Eisai R & D Management Co., Ltd. |
Heterocyclic type cinnamide derivative
|
|
AR062095A1
(es)
|
2006-07-28 |
2008-10-15 |
Eisai R&D Man Co Ltd |
Profarmaco de compuesto cinamida
|
|
WO2008036540A2
(en)
|
2006-09-20 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
CL2008000582A1
(es)
|
2007-02-28 |
2008-06-27 |
Eisai R&D Man Co Ltd |
Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
|
|
PE20090044A1
(es)
|
2007-04-06 |
2009-01-23 |
Neurocrine Biosciences Inc |
Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
|
|
CL2008000986A1
(es)
|
2007-04-06 |
2008-10-17 |
Neurocrine Biosciences Inc |
COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
|
|
WO2008140111A1
(ja)
*
|
2007-05-16 |
2008-11-20 |
Eisai R & D Management Co., Ltd. |
シンナミド誘導体のワンポット製造方法
|
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
|
CA2697081C
(en)
|
2007-08-22 |
2013-04-23 |
Irm Llc |
5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors
|
|
US7935815B2
(en)
*
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
ES2529648T3
(es)
|
2007-08-31 |
2015-02-24 |
Eisai R&D Management Co., Ltd. |
Compuesto policíclico
|
|
PL2201012T3
(pl)
|
2007-10-11 |
2014-11-28 |
Astrazeneca Ab |
Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
|
|
BRPI0820171B8
(pt)
|
2007-11-16 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
compostos de carboxamida, sulfonamida e amina para distúrbios metabólicos, composição farmacêutica, e, uso dos mesmos
|
|
CA2707047C
(en)
|
2007-12-12 |
2017-11-28 |
Rigel Pharmaceuticals, Inc. |
Carboxamide, sulfonamide and amine compounds for metabolic disorders
|
|
MX2010005704A
(es)
*
|
2007-12-18 |
2010-08-17 |
Glenmark Pharmaceuticals Sa |
Derivados de cromano como modulares del trpv3.
|
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
US20100317860A1
(en)
*
|
2008-01-28 |
2010-12-16 |
Ikuo Kushida |
Crystalline cinnamide compounds or salts thereof
|
|
US8193202B2
(en)
|
2008-04-21 |
2012-06-05 |
Lexicon Pharmaceuticals, Inc. |
LIMK2 inhibitors, compositions comprising them, and methods of their use
|
|
MX2010011288A
(es)
|
2008-04-23 |
2010-11-09 |
Rigel Pharmaceuticals Inc |
Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
|
|
MX2010011762A
(es)
|
2008-06-17 |
2011-02-03 |
Glenmark Pharmaceuticals Sa |
Derivados de cromano como moduladores del trpv3.
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
JP4884570B2
(ja)
*
|
2008-08-20 |
2012-02-29 |
ファイザー・インク |
ピロロ［２，３−ｄ］ピリミジン化合物
|
|
WO2010052448A2
(en)
*
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
|
EP3053913B1
(en)
|
2009-05-01 |
2018-03-07 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
|
JP5775070B2
(ja)
|
2009-05-22 |
2015-09-09 |
インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ |
ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体
|
|
SG176111A1
(en)
|
2009-05-22 |
2011-12-29 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
|
CA2776028C
(en)
*
|
2009-10-15 |
2015-12-01 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
US20110130415A1
(en)
|
2009-12-01 |
2011-06-02 |
Rajinder Singh |
Protein kinase c inhibitors and uses thereof
|
|
WO2011089416A1
(en)
|
2010-01-19 |
2011-07-28 |
Astrazeneca Ab |
Pyrazine derivatives
|
|
PT3354652T
(pt)
|
2010-03-10 |
2020-07-20 |
Incyte Holdings Corp |
Derivados de piperidin-4-ilazetidina como inibidores de jak1
|
|
RS54824B1
(sr)
|
2010-05-21 |
2016-10-31 |
Incyte Holdings Corp |
Topikalna formulacija za inhibiciju jak-a
|
|
CN103180321A
(zh)
|
2010-09-23 |
2013-06-26 |
Abbvie公司 |
氮杂金刚烷衍生物的一水合物
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
EP2694056B1
(en)
|
2011-04-01 |
2019-10-16 |
AstraZeneca AB |
Therapeutic treatment
|
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
PH12014500943A1
(en)
|
2011-11-30 |
2014-06-30 |
Astrazeneca Ab |
Combination treatment of cancer
|
|
CA2857603C
(en)
|
2011-12-15 |
2016-08-02 |
Pfizer Limited |
Sulfonamide derivatives
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
EP2858501A4
(en)
*
|
2012-05-22 |
2015-12-09 |
Merck Sharp & Dohme |
TRKA KINASE INHIBITORS, COMPOSITIONS AND METHOD THEREFOR
|
|
CN113384546A
(zh)
|
2012-11-15 |
2021-09-14 |
因赛特公司 |
鲁索利替尼的缓释剂型
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
WO2014134391A1
(en)
|
2013-02-28 |
2014-09-04 |
Bristol-Myers Squibb Company |
Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
|
|
WO2014138168A1
(en)
|
2013-03-06 |
2014-09-12 |
Incyte Corporation |
Processes and intermediates for making a jak inhibitor
|
|
DK3811943T3
(da)
|
2013-03-15 |
2023-04-03 |
Aerie Pharmaceuticals Inc |
Forbindelse til anvendelse til behandling af øjenlidelser
|
|
SG10201801069QA
(en)
|
2013-08-07 |
2018-03-28 |
Incyte Corp |
Sustained release dosage forms for a jak1 inhibitor
|
|
CN103910715B
(zh)
*
|
2014-03-26 |
2016-03-02 |
深圳翰宇药业股份有限公司 |
一种别嘌醇杂质c的合成方法
|
|
US9527812B2
(en)
|
2014-05-01 |
2016-12-27 |
Northwestern University |
N-heterocyclic carbene-catalyzed synthesis of 2-aryl indoles
|
|
WO2015170218A1
(en)
|
2014-05-07 |
2015-11-12 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
RS62017B1
(sr)
|
2014-09-17 |
2021-07-30 |
Celgene Car Llc |
Mk2 inhibitori i njihova upotreba
|
|
EP3365334B1
(en)
|
2015-10-21 |
2024-07-17 |
Otsuka Pharmaceutical Co., Ltd. |
Benzolactam compounds as protein kinase inhibitors
|
|
US10550087B2
(en)
|
2015-11-17 |
2020-02-04 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
WO2017102091A1
(en)
|
2015-12-18 |
2017-06-22 |
Bayer Pharma Aktiengesellschaft |
Heteroarylbenzimidazole compounds
|
|
ES2844926T3
(es)
*
|
2016-05-12 |
2021-07-23 |
Boehringer Ingelheim Int |
Derivados de piridinilo, composiciones farmacéuticas y usos de los mismos como inhibidores de AOC3
|
|
WO2017207534A1
(en)
|
2016-06-03 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Substituted heteroarylbenzimidazole compounds
|
|
CN107663202B
(zh)
*
|
2016-07-29 |
2020-09-04 |
西华大学 |
3-(脲基-甲基)-4-芳基-吡啶衍生物及其制备方法和作为抗肝癌药物的应用
|
|
KR102568079B1
(ko)
|
2016-08-31 |
2023-08-17 |
에어리 파마슈티컬즈, 인코포레이티드 |
안과용 조성물
|
|
CR20220309A
(es)
|
2016-09-02 |
2022-09-16 |
Cyclerion Therapeutics Inc |
Estimuladores de sgc
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
KR20190135027A
(ko)
|
2017-03-31 |
2019-12-05 |
에어리 파마슈티컬즈, 인코포레이티드 |
아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물
|
|
GB201706327D0
(en)
|
2017-04-20 |
2017-06-07 |
Otsuka Pharma Co Ltd |
A pharmaceutical compound
|
|
WO2018204532A1
(en)
*
|
2017-05-03 |
2018-11-08 |
Vivace Therapeutics, Inc. |
Non-fused tricyclic compounds
|
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
|
EA202091830A1
(ru)
|
2018-01-30 |
2020-12-29 |
Инсайт Корпорейшн |
Способы и промежуточные соединения для получения ингибитора jak
|
|
BR122023024273A2
(pt)
|
2018-02-27 |
2024-02-20 |
Incyte Corporation |
Compostos imidazopirimidinas e triazolopirimidinas, seus usos, método para inibir uma atividade de um receptor de adenosina e composição farmacêutica dos mesmos
|
|
MD3773593T2
(ro)
|
2018-03-30 |
2024-10-31 |
Incyte Corp |
Tratament hidradenitei supurative utilizând inhibitori ai JAK
|
|
WO2019222677A1
(en)
|
2018-05-18 |
2019-11-21 |
Incyte Corporation |
Fused pyrimidine derivatives as a2a / a2b inhibitors
|
|
GEP20237548B
(en)
|
2018-07-05 |
2023-10-10 |
Incyte Corp |
Fused pyrazine derivatives as a2a /a2b inhibitors
|
|
AU2019337703B2
(en)
|
2018-09-14 |
2023-02-02 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
US12213970B2
(en)
|
2018-10-29 |
2025-02-04 |
Boehringer Ingelheim International Gmbh |
Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
|
|
DK3873600T5
(da)
|
2018-10-29 |
2024-03-18 |
Boehringer Ingelheim Int |
Pyridinylsulfonamidderivater, farmaceutiske sammensætninger og anvendelser deraf
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
|
WO2020180959A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
US11440914B2
(en)
|
2019-05-01 |
2022-09-13 |
Incyte Corporation |
Tricyclic amine compounds as CDK2 inhibitors
|
|
AU2020321955A1
(en)
|
2019-07-30 |
2022-03-17 |
Eikonizo Therapapeutics, Inc. |
HDAC6 inhibitors and uses thereof
|
|
TW202115024A
(zh)
|
2019-08-14 |
2021-04-16 |
美商英塞特公司 |
作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
|
|
EP4021893A1
(en)
*
|
2019-08-29 |
2022-07-06 |
Hibercell, Inc. |
Perk inhibiting compounds
|
|
AU2020364007A1
(en)
|
2019-10-11 |
2022-04-28 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
LT4081305T
(lt)
|
2019-12-24 |
2024-11-25 |
Carna Biosciences, Inc. |
Diacilglicerolio kinazę moduliuojantys junginiai
|
|
KR20260017503A
(ko)
|
2020-02-14 |
2026-02-05 |
길리애드 사이언시즈, 인코포레이티드 |
Ccr8에 결합하는 항체 및 융합 단백질, 및 이의 용도
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
CA3222277A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271677A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271659A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
KR20240005901A
(ko)
|
2021-06-23 |
2024-01-12 |
길리애드 사이언시즈, 인코포레이티드 |
디아실글리세롤 키나제 조절 화합물
|
|
US20230183216A1
(en)
|
2021-10-28 |
2023-06-15 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
EP4422756A1
(en)
|
2021-10-29 |
2024-09-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
CN118488946A
(zh)
|
2021-12-22 |
2024-08-13 |
吉利德科学公司 |
Ikaros锌指家族降解剂及其用途
|
|
EP4452415B1
(en)
|
2021-12-22 |
2026-02-25 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
CA3253296A1
(en)
|
2022-03-17 |
2023-09-21 |
Gilead Sciences, Inc. |
Zinc Finger Degradation Agents of the Ikaros Family and Their Uses
|
|
IL316201A
(en)
|
2022-04-08 |
2024-12-01 |
Eikonizo Therapeutics Inc |
Oxadiazole HDAC6 inhibitors and their uses
|
|
WO2023205719A1
(en)
|
2022-04-21 |
2023-10-26 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20240116928A1
(en)
|
2022-07-01 |
2024-04-11 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
EP4638436A1
(en)
|
2022-12-22 |
2025-10-29 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN120882725A
(zh)
|
2023-04-11 |
2025-10-31 |
吉利德科学公司 |
Kras调节化合物
|
|
WO2024220917A1
(en)
|
2023-04-21 |
2024-10-24 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20250042922A1
(en)
|
2023-06-30 |
2025-02-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
US20250066328A1
(en)
|
2023-07-26 |
2025-02-27 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
AU2024297978A1
(en)
|
2023-07-26 |
2026-02-05 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
WO2025054347A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
AU2024337913A1
(en)
|
2023-09-08 |
2026-03-26 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
US20250376484A1
(en)
|
2024-05-21 |
2025-12-11 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2026039365A1
(en)
|
2024-08-12 |
2026-02-19 |
Gilead Sciences, Inc. |
Kras modulating compounds
|